Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma. [electronic resource]
Producer: 20180612Description: 1816-1819 p. digitalISSN:- 1476-5551
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Induction Chemotherapy
- Lenalidomide
- Male
- Middle Aged
- Multiple Myeloma -- therapy
- Survival Analysis
- Thalidomide -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.